Adamas Pharmaceuticals, Inc.
$400M
Adamas is a California-based pharmaceutical company that develops and commercializes therapies for the treatment of neurological diseases.
US WorldMeds, LLC
$300M
US WorldMeds is a pharmaceutical company that develops and commercializes therapies for the treatment of idiopathic parkinson's disease.
Biscayne NeuroTherapeutics
$15M
Biscayne is a clinical-stage biotechnology company developing drugs for the treatment of neurological disorders.
-
Drug Formulation Business,Shire Laboratories Inc
undisclosed
-